Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josefa Leon

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Pineal Research|August 16, 2005
Interactions between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatoninDun-Xian Tan, Lucien C Manchester, Rosa M Sainz, et al.
Polish Journal of Pharmacology|May 25, 2004
Pharmacological utility of melatonin in reducing oxidative cellular and molecular damageRussel J Reiter, Dun-Xian Tan, Eloisa Gitto, et al.
Frontiers in Endocrinology|April 4, 2022
In Obese Patients With Type 2 Diabetes, Mast Cells in Omental Adipose Tissue Decrease the Surface Expression of CD45, CD117, CD203c, and FcϵRIDavid Lopez-Perez, Anaïs Redruello-Romero, Jesús Garcia-Rubio, et al.
Frontiers in Immunology|June 7, 2021
In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 DiabetesDavid Lopez-Perez, Anaïs Redruello-Romero, Jesús Garcia-Rubio, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Pineal Research|August 16, 2005
Interactions between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatoninDun-Xian Tan, Lucien C Manchester, Rosa M Sainz, et al.
Polish Journal of Pharmacology|May 25, 2004
Pharmacological utility of melatonin in reducing oxidative cellular and molecular damageRussel J Reiter, Dun-Xian Tan, Eloisa Gitto, et al.
Frontiers in Endocrinology|April 4, 2022
In Obese Patients With Type 2 Diabetes, Mast Cells in Omental Adipose Tissue Decrease the Surface Expression of CD45, CD117, CD203c, and FcϵRIDavid Lopez-Perez, Anaïs Redruello-Romero, Jesús Garcia-Rubio, et al.
Frontiers in Immunology|June 7, 2021
In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 DiabetesDavid Lopez-Perez, Anaïs Redruello-Romero, Jesús Garcia-Rubio, et al.
Pageof 2